In this study, a high-performance T 1 -T 2 dual-model contrast agent by gadolinium-doped iron oxide nanoparticle (GION) is developed. Following its development, the application of this agent in vivo by combining doxorubicin (DOX) and folic acid (FA) (FA-GION-DOX) for targeted drug delivery to monitor cancer treatment is explored. GION showed transverse and longitudinal relaxivities up to 182.7 × 10 −3 and 7.87 × 10